Global Single-Use Bioreactor Systems Market - Strategic Insights And Forecasts, 2026-2031 US$8.6 Billion By 2031 As Biologics, AI, And CDMO Demand Fuel 9% CAGR
Dublin, Oct. 01, 2026 (GLOBE NEWSWIRE) -- "Single-Use Bioreactor Systems Market - Strategic Insights and Forecasts (2026-2031)" has been added to ResearchAndMarkets.com's offering.
The global Single-Use Bioreactor Systems market is projected to grow from USD 5.6 billion in 2026 to USD 8.6 billion by 2031, progressing at a CAGR of 9.0%. Market expansion is being supported by growing biologics production, demand for flexible biomanufacturing, and continued investment in vaccines, monoclonal antibodies, recombinant proteins, and cell and gene therapies.
Single-use bioreactor systems are gaining importance across research, clinical development, and commercial manufacturing. Their scalability, shorter setup times, and compatibility with modular production environments help biopharmaceutical companies accelerate production cycles and reduce time-to-market. Adoption is also increasing among contract development and manufacturing organizations seeking adaptable platforms for multiple products and batch sizes.
Key Single-Use Bioreactor Systems Market Drivers
Expansion of the global biopharmaceutical industry remains a major market driver. Strong clinical pipelines for biologics and advanced therapy medicinal products require manufacturing systems that support sterility, rapid changeovers, and scalable production. Single-use platforms address these requirements across early-stage development and large-scale manufacturing.
The rising prevalence of chronic and rare diseases is increasing demand for targeted biologic therapies. At the same time, personalized medicine and small-batch production are encouraging manufacturers to deploy modular systems that can accommodate changing production requirements.
Cost efficiency also supports market adoption. Single-use systems reduce cleaning validation requirements, water and energy consumption, and capital investment in permanent manufacturing infrastructure. These advantages are particularly relevant to small and mid-sized biotechnology companies, contract research organizations, and contract manufacturing organizations.
Market Challenges and Restraints
Environmental concerns associated with disposable plastic components remain a significant challenge for the Single-Use Bioreactor Systems market. Higher waste volumes may attract additional regulatory scrutiny and increase sustainability-related compliance costs. Manufacturers are responding through material innovation, waste reduction programs, and hybrid production models.
Recurring expenditure on consumables can also affect long-term operating budgets. Supply chain reliability, component availability, extractables and leachables, and material compatibility may influence purchasing decisions, particularly for large-scale facilities requiring consistent performance across high production volumes.
Technology and Segment Insights
The market is analyzed by product type, cell type, molecule type, end-user, and region. Single-use bioreactor systems hold a leading position due to their integration within upstream bioprocessing workflows and ability to support capacity expansion without extensive facility modifications.
Mammalian cells account for a substantial market share, reflecting their widespread use in monoclonal antibody and biologics production. Monoclonal antibodies and vaccines remain prominent molecule segments, supported by global demand, extensive development pipelines, and expanding manufacturing capacity.
Primary end-users include pharmaceutical and biopharmaceutical companies, contract research organizations, contract manufacturing organizations, and academic institutes. Contract manufacturers are increasing adoption to reduce setup time, improve production flexibility, and serve clients with diverse process requirements.
Sensor integration, automation, and AI-driven process optimization are improving real-time monitoring, process control, yield consistency, and operational efficiency. These developments are expected to strengthen the role of single-use systems in next-generation biomanufacturing.
Competitive Landscape and Strategic Outlook
Leading market participants include Thermo Fisher Scientific, Danaher, Merck KGaA, Eppendorf AG, and Sartorius. These companies are investing in product development, manufacturing capacity, advanced single-use platforms, and broader bioprocessing portfolios.
Strategic priorities include new product launches, partnerships with contract manufacturers, geographic expansion, and investment in modular biomanufacturing facilities. Hybrid systems combining single-use and reusable technologies are also attracting interest as companies seek to balance operational flexibility, cost management, and sustainability objectives.
The long-term outlook for the global Single-Use Bioreactor Systems market remains positive. Rising biologics demand, expanding applications in advanced therapies, and ongoing technology innovation are expected to support sustained growth through 2031, despite challenges related to waste management, recurring consumable costs, and supply chain resilience.
Key Benefits of the Report
- Analysis of regional markets, customer segments, policies, socio-economic factors, industry verticals, and purchasing trends Assessment of market drivers, restraints, emerging technologies, and future growth opportunities Competitive intelligence covering strategic initiatives, market positioning, and entry approaches Actionable recommendations supporting investment, expansion, and revenue development decisions Insights relevant to startups, research institutions, consultants, SMEs, and large enterprises
Business Applications
Organizations use the report for market opportunity assessment, product demand forecasting, market entry strategy, geographical expansion, capital investment planning, regulatory analysis, new product development, supply chain evaluation, and competitive intelligence.
Report Coverage
- Historical data from 2021 to 2025 and forecast data from 2026 to 2031 Market growth opportunities, challenges, supply chain outlook, regulatory framework, and trend analysis Competitive positioning, corporate strategies, and market share evaluation Revenue forecasts across major segments and regions Company profiles covering strategies, products, financial performance, and key developments
For more information about this report visit
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept any
responsibility or liability for the accuracy, content, images, videos,
licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright issues
related to this article, kindly contact the provider above.
Comments
No comment